Breakthrough Psychological Solutions

Strategies of Big Pharma: Retaining Market Share and Profitability for ADHD Medications

Posted by Jerry Smith on Friday, April 26, 2024

Strategies of Big Pharma: Retaining Market Share and Profitability for ADHD Medications

image by author

The pharmaceutical industry plays a critical role in shaping how ADHD (Attention-Deficit/Hyperactivity Disorder) is perceived, diagnosed, and treated. As with any industry, the goal is not just to introduce a successful product but also to ensure its continued profitability. As popular ADHD medications lose their patent protections, pharmaceutical companies employ a v...


Continue reading...
 

Direct-to-Consumer Advertising of ADHD Medications: Impacts on Diagnosis Rates and Public Perception

Posted by Jerry Smith on Friday, April 26, 2024

Direct-to-Consumer Advertising of ADHD Medications: Impacts on Diagnosis Rates and Public Perception

Introduction

In the realm of healthcare, few topics have been as hotly debated as the direct-to-consumer (DTC) advertising of prescription medications. DTC advertising is where pharmaceutical companies market prescription medications directly to the public, typically through mediums such as television, radio, print, and digital channels. One of the most controversial are...


Continue reading...
 

The Rising Global Demand for ADHD Medications

Posted by Jerry Smith on Friday, April 26, 2024



The Rising Global Demand for ADHD Medications

image by author

Attention-Deficit/Hyperactivity Disorder (ADHD) is not an exclusively Western or American phenomenon. Although ADHD has been extensively studied and diagnosed in Western nations, particularly in the U.S., the recognition and diagnosis of this condition are on the rise globally. With this increased awareness comes a mounting demand for medications known to treat ADHD. But why is there a surge in the global app...


Continue reading...
 

International Perceptions and Guidelines of ADHD: The Role of Big Pharma

Posted by Jerry Smith on Friday, April 26, 2024

International Perceptions and Guidelines of ADHD: The Role of Big Pharma

Attention-Deficit/Hyperactivity Disorder (ADHD) is a well-documented and researched neurodevelopmental disorder with increasing prevalence rates across the globe. As with many medical conditions, its understanding, diagnosis, and treatment approaches vary by country and culture. Moreover, the pharmaceutical industry, often termed “Big Pharma,” plays a considerable role in shaping these guideli...


Continue reading...
 

The Transformative Power of Integrative Medicine on Mental Health

Posted by Jerry Smith on Friday, April 26, 2024



The Transformative Power of Integrative Medicine on Mental Health

As a practicing psychologist deeply entrenched in the world of mental health care, I’ve witnessed firsthand the transformative effects of integrated medicine on my clients. The journey towards healing is not a one-size-fits-all path, and incorporating elements of integrated medicine has proven to be a game-changer for many individuals struggling with their mental health.

image by author

A Personal Journe...


Continue reading...
 

The Ethical Dilemma: Prescribing Stimulant Medications for Children with ADHD

Posted by Jerry Smith on Friday, April 26, 2024



The Ethical Dilemma: Prescribing Stimulant Medications for Children with ADHD

image by author

In an era where the prescription of stimulant medications for Attention Deficit Hyperactivity Disorder (ADHD) is commonplace, a rising ethical debate has emerged regarding their use, especially in pediatric populations. This discourse revolves around the short-term and long-term implications of these medications, their potential overprescription, and the balance between potenti...


Continue reading...
 

Equitable Access to ADHD Medications Worldwide: Barriers and Pathways

Posted by Jerry Smith on Friday, April 26, 2024



Equitable Access to ADHD Medications Worldwide: Barriers and Pathways

image by author

The global discourse on ADHD (Attention-Deficit/Hyperactivity Disorder) has surged in the past few decades, primarily due to increased awareness, research, and advocacy. However, access to ADHD medications, often considered the frontline treatment, varies substantially across the world. This inconsistency isn’t solely based on genuine medical disagreements but is intertwined with eco...


Continue reading...
 

AI and the Future of Healthcare: Revolutionizing Mental Health Integration Within Two Years

Posted by Jerry Smith on Friday, April 26, 2024

AI and the Future of Healthcare: Revolutionizing Mental Health Integration Within Two Years

image by author

In recent years, the intersection of medicine and mental health has garnered increasing attention, highlighting a crucial gap in our healthcare system. Despite the interconnectedness of physical and mental well-being, treatments for these domains often operate in silos. This separation not only complicates the patient care process but also overlooks the nuanced in...


Continue reading...
 

Mind Over Matter: The Psychological Preparation of Special Forces Units

Posted by Jerry Smith on Friday, April 26, 2024

Mind Over Matter: The Psychological Preparation of Special Forces Units

image by author

The Essence of Psychological Resilience in Special Forces Training

In the world of Special Forces training, psychological resilience stands as a cornerstone for success. These elite units operate in high-stress environments where split-second decisions and unwavering determination can mean the difference between success and failure, life and death. While physical prowess is undoubtedl...


Continue reading...
 

New Book Alert: “Big Pharma Says You Have ADHD!” Unveils the Impact of Big Pharma on ADHD Narratives

Posted by Jerry Smith on Friday, April 26, 2024




Continue reading...